Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2011-02-03 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the header that it is a 'Voting Rights Announcement' and references Article 26, Section 1 of the WpHG (German Securities Trading Act). The content details changes in the percentage holding of voting rights by specific entities (Artio Global Investors Inc., Artio Global Holdings LLC, Artio Global Management LLC) falling below the 3% threshold. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-02-03 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification pursuant to Article 26, Section 1 of the WpHG (German Securities Trading Act). It reports that a shareholder's percentage holding of voting rights crossed below specific thresholds (50% and 30%) and states the resulting holding percentage. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related voting rights changes.
2011-02-03 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details changes in the percentage holding of voting rights by Allianz SE and its subsidiaries in Fresenius SE & Co. KGaA, referencing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related voting rights notifications.
2011-02-01 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of January 31, 2011, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, detailing the total number of shares carrying voting rights, is a specific regulatory disclosure. Among the provided codes, none perfectly match a 'Total Voting Rights Announcement' directly. However, this information is often released alongside or as part of general regulatory disclosures or shareholder-related updates. Since it is a mandatory regulatory disclosure about the capital structure (voting rights), and it is not a dividend announcement (DIV), director dealing (DIRS), or a major shareholding change (MRQ) by an external party, it falls best under the general 'Regulatory Filings' (RNS) category as a miscellaneous mandatory filing, or potentially related to voting rights (DVA), but DVA is specifically for *results* of votes. Given the nature of mandatory disclosure about the total share count, RNS is the most appropriate fallback for this specific type of regulatory notice not covered elsewhere.
2011-01-31 English
Commerzbank German Investment Seminar
Investor Presentation Classification · 98% confidence The document is titled "Commerzbank German Investment Seminar" and contains detailed financial tables, segment updates (Fresenius Medical Care, Kabi, Helios, Vamed), outlook revisions, and Profit and Loss/Cash Flow statements. The content is highly specific, covering operational and financial performance across multiple business segments, which is characteristic of an Investor Presentation or a Management Discussion and Analysis (MDA) accompanying results. Since it is presented as a seminar/presentation format (indicated by the title and structure) and contains forward-looking statements and detailed segment breakdowns, it strongly aligns with the definition of an Investor Presentation (IP). It is too detailed to be a simple Earnings Release (ER) and is not a formal regulatory filing like a 10-K or IR. The date (January 10-12, 2011) suggests it is presenting results or outlook related to the preceding period (Q3/10 updates are mentioned).
2011-01-18 English
Cheuvreux 10th German Corporate Conference
Investor Presentation Classification · 98% confidence The document is titled "Cheuvreux – 10th German Corporate Conference" and is dated January 17, 2011. It contains detailed financial tables, outlook updates, segment performance reviews (Fresenius Medical Care, Kabi, Helios, Vamed), and concludes with attachments showing Profit and Loss Statements and Cash Flow statements. This structure—a presentation summarizing recent performance, providing outlook guidance, and including detailed financial schedules—is characteristic of an Investor Presentation (IP) delivered at a conference or investor event, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which is typically shorter and more focused on the initial announcement. The content is clearly designed for investors.
2011-01-17 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.